Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Cancer
|
November 20, 2019
Patient-reported outcomes in the Translational Breast Cancer Research Consortium
Deborah J Bowen, Eileen H Shinn, Sophie Gregrowski, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
September 24, 2025
Purpose in life and mortality among breast cancer survivors
Juhua Luo, Stephanie A Hooker, Candyce H Kroenke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 25, 2024
Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer
Catherine E Mosher, Shieun Lee, Elizabeth L Addington, et al.
JAMA Oncology
|
December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial
Brian D Lehmann, Vandana G Abramson, E Claire Dees, et al.
Cardio-Oncology (London, England)
|
December 18, 2025
Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal women
Kerryn W Reding, Alexi L Vasbinder, Richard K Cheng, et al.
Cancer Discovery
|
October 4, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M Tung, Mark E Robson, Steffen Ventz, et al.
JCO Oncology Practice
|
July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Cancer Research Communications
|
April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Cancer
|
November 20, 2019
Patient-reported outcomes in the Translational Breast Cancer Research Consortium
Deborah J Bowen, Eileen H Shinn, Sophie Gregrowski, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
September 24, 2025
Purpose in life and mortality among breast cancer survivors
Juhua Luo, Stephanie A Hooker, Candyce H Kroenke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 25, 2024
Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer
Catherine E Mosher, Shieun Lee, Elizabeth L Addington, et al.
JAMA Oncology
|
December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial
Brian D Lehmann, Vandana G Abramson, E Claire Dees, et al.
Cardio-Oncology (London, England)
|
December 18, 2025
Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal women
Kerryn W Reding, Alexi L Vasbinder, Richard K Cheng, et al.
Cancer Discovery
|
October 4, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M Tung, Mark E Robson, Steffen Ventz, et al.
JCO Oncology Practice
|
July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Cancer Research Communications
|
April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
Page
of 5